Medwise.ai
- Company typePrivate
- Founded2019
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Medwise.ai firmographics
Firmographics- Name
- Medwise.ai
- Legal name
- MEDWISE AI LTD
- Website
- https://medwise.ai
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Medwise.ai industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Virtual Second Opinion & Care Navigation Platforms (HLALAAAF)
- akta.pro secondary industries
- Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Second Opinion & Expert Matching Platforms (HLALALAC)
Keywords
Where Medwise.ai is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Medwise.ai business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Plus Subscription (Freemium Upgrade): Free tier for verified healthcare professionals and students. Plus subscription provides faster responses, larger document uploads (60 pages vs 20), priority support, and personalised search instructions. Plus access is earned by referring others or may require paid subscription.
- Referral Monetisation: Users receive Plus access by referring others who sign up. Corporate or bulk access may involve paid subscriptions for organisations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free tier for verified NHS healthcare professionals |
| Subscription | Monthly | Plus subscription with enhanced features |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Medwise.ai product offering
Product offeringCore offering
Medwise.ai operates an AI-powered medical information search platform designed for UK healthcare professionals. It provides multi-mode search across trusted medical sources (including UK SPCs and Tariffs), automated CPD entry generation, document upload and sharing, and NHSmail authentication. Access is free for verified NHS staff with an optional Plus subscription offering priority server access, larger uploads, and personalised search customisation.
Product overview
Medwise.ai offers a unified AI-powered medical information platform primarily delivered as a web application with companion mobile apps for iOS and Android. The core Medwise AI Platform provides multi-modal search capabilities across trusted medical literature with specialized modes for drug information (UK SPCs and Tariffs), clinical guidance, and local services. The product portfolio includes the free tier for NHS healthcare professionals and a Plus subscription add-on offering priority access, larger uploads, and enhanced customisation. Supporting features include CPD Entry Management for tracking professional development and Document Folders for collaborative reference management. All offerings are designed exclusively for UK healthcare professionals and are not regulated medical devices.
Differentiator
Problem solved
Functional benefit
Products and services
- Medwise AI Platform
Quantifiable outcome
- Trusted by thousands of clinicians across 2000+ NHS organisations
Companies that use Medwise.ai
Customer profileNamed customers12 records
Segments3 records
Ideal customer profiles3 records
Medwise.ai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature4 records
Medwise.ai partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Mount Sinai - Elementa LabscoreLaunched from the Mount Sinai Elementa Labs program, which supports healthcare innovation startups. This partnership provided validation and support during the company's early development stages, associating Medwise.ai with a leading US healthcare institution.
- Cure by Deerfield Middle East Health AcceleratorminorSelected to participate in the inaugural 12-week accelerator program in Qatar, launched through collaboration with Deerfield Management, Qatar Investment Authority, and Qatar Development Bank. Program includes training in valuation, fundraising, and market strategy.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Medwise.ai competitors and assessment
Company assessmentDirect peers
- Nabla: AI copilot for clinicians offering ambient note generation and clinical reference. Targets the same clinician-AI-assistant category as Medwise with comparable multi-modal capabilities.
- Glass Health: AI clinical decision support platform that helps clinicians draft diagnoses and treatment plans. Directly comparable AI-for-clinicians product with overlapping search-and-summarisation functionality.
- OpenEvidence: US-based AI medical search engine for clinicians, founded by Daniel Nadler. Directly competes in the AI-powered clinical information retrieval category, though focused on US clinicians and peer-reviewed literature rather than UK NHS-specific content.
- TORTUS AI: UK-based AI clinical assistant (OSCAR) integrated with NHS workflows. Most direct UK-centric competitor, also serving NHS clinicians with similar ambient documentation and clinical reference tools.
- Atropos Health: Clinical evidence search and real-world data platform for physicians. Overlaps with Medwise's evidence-retrieval value proposition while adding health-system analytics layers.
- Suki AI: AI-powered clinical assistant for clinicians combining ambient documentation, search, and summarisation. Closest direct competitor in clinician-facing AI workflow tools with similar freemium-to-enterprise monetisation model.
Broad incumbents
- Abridge: Well-funded ambient AI scribe and clinical conversation platform. While primarily documentation-focused, it increasingly expands into clinician search and reference — adjacent category with overlapping buyer.
- Doximity GPT (DocsGPT): US physician network with built-in GPT-powered clinical assistant. Competes in AI tools for clinicians with the advantage of a massive established US physician user base and subscription platform.
Emerging players
- Hippocratic AI: Healthcare-focused LLM company building clinical AI agents. Targets the same clinician AI-assistant category as Medwise but with a much larger funding base and broader clinical workflow ambition.
- Pathway Medical: AI medical reference platform for clinicians using evidence-based sources. Comparable in offering AI-curated medical information to physicians, though more generalist than UK-NHS-specific.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Medwise.ai compliance and trust
Trust signalCompliance1 record
Medwise.ai financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medwise.ai leadership team
Management profileNumber of profiles
Profiles2 records
Medwise.ai funding detail
Funding detailFunding overview
Funding rounds9 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medwise.ai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medwise.ai
What does Medwise.ai do?
Medwise.ai operates an AI-powered medical information search platform designed for UK healthcare professionals. It provides multi-mode search across trusted medical sources (including UK SPCs and Tariffs), automated CPD entry generation, document upload and sharing, and NHSmail authentication. Access is free for verified NHS staff with an optional Plus subscription offering priority server access, larger uploads, and personalised search customisation.
Is Medwise.ai a public or private company?
Medwise.ai is a private company. It is classified as venture growth investor backed and is currently operating.
When was Medwise.ai founded?
Medwise.ai was founded in 2019. It employs 1 to 10 people.
Where is Medwise.ai based?
Medwise.ai is headquartered in London, United Kingdom, in the Europe region.
How does Medwise.ai make money?
Two revenue lines are on record. Plus Subscription (Freemium Upgrade) is the primary driver. The others are referral Monetisation.
Who are Medwise.ai's main competitors?
Direct peers on record are Nabla, Glass Health, OpenEvidence, TORTUS AI, Atropos Health and Suki AI. Broad incumbents are Abridge and Doximity GPT (DocsGPT). Emerging players are Hippocratic AI and Pathway Medical.
Does Medwise.ai have an API?
No public API is recorded for Medwise.ai.
What industry is Medwise.ai in?
Medwise.ai's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLALAAAF, Virtual Second Opinion & Care Navigation Platforms, with a secondary code of HLACAFAH, Virtual Nursing, Telemonitoring & Command Center Platforms. Its NAICS code is 62111 and its SIC code is 8000.